Skip to main content
  • Original article
  • Open access
  • Published:

Nocturnal heart rate variability in obstructive sleep apnea syndrome: effect of automatic positive airway pressure

Abstract

Background

The cyclic hypoxemia and arousal characteristic of obstructive sleep apnea (OSA) causes dysregulation in the autonomic nervous system (ANS) resulting in cardiac rhythm disturbances. Positive airway pressure therapy in OSA results in ANS regulation. This study aimed at investigating the effects of automatic positive airway pressure (APAP) over nocturnal heart rate variability (HRV) in OSA and to further identify this effect in hypertensive versus normotensive OSA patients.

Patients and methods

A total of 25 patients (four with moderate and 21 with severe OSA) were included (male/ female: 22/3; mean age 49.52±15.69 years). Patients were subdivided into two groups: 13 (52%) normotensive and 12 (48%) hypertensive patients. Two overnight sleep studies with polysomnographic-based nocturnal HRV were carried out: the first study was diagnostic, whereas the second one was an APAP titration study.

Results

APAP results in significant reduction in most of time and frequency-domain indexes [except for standard deviation of average NN interval (SDANN, P=0.106), HRV triangular index (HRV TI, P=0.057), and high-frequency power (HF, P=0.109)]; RR interval (P=0.024), standard deviation of all RR intervals (SDNN, P=0.012), mean of the standard deviation of all RR intervals for all 5-min segments (SDNN Index, P=0.009), square root of the mean of the sum of the squares of differences between adjacent RR intervals (RMSSD, P=0.002), number of pairs of adjacent RR intervals differing by more than 50 ms in the entire analysis interval (NN50 count, P=0.004), NN50 count divided by the total number of all RR intervals (%NN50, P=0.001), total power (P=0.010), very low-frequency power (VLF, P=0.018), low-frequency power (LF, P=0.008), and low frequency/high frequency (LF/HF, P=0.012). HRV did not differ significantly between the two groups either before or after APAP; however, most of the time-domain and frequency-domain HRV indexes decreased significantly with APAP in the hypertensive group.

Conclusion

Nocturnal HRV improved with APAP in OSA. APAP was more beneficial in terms of ANS regulation in OSA patients with coexisting hypertension than normotensive OSA patients.

References

  1. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, et al. Positive Airway Pressure Titration Task Force of the American Academy of Sleep Medicine. Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea. J Clin Sleep Med 2008; 4:157–171.

    Article  Google Scholar 

  2. Tilkian AG, Guilleminault C, Schroeder JS, Lehrman KL, Simmons FB, Dement WC. Sleep-induced apnea syndrome: prevalence of cardiac arrhythmias and their reversal after tracheostomy. Am J Med 1977; 63:348–358.

    Article  CAS  Google Scholar 

  3. Zwillich C, Devlin T, White D, Douglas N, Weil J, Martin R. Bradycardia during sleep apnea: characteristics and mechanism. J Clin Invest 1982; 69:1286–1292.

    Article  CAS  Google Scholar 

  4. Guilleminault C, Connolly SJ, Winkle RA. Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. Am J Cardiol 1983; 52:490–494.

    Article  CAS  Google Scholar 

  5. Hoffstein V, Sateika S. Cardiac arrhythmias, snoring, and sleep apnea. Chest 1994; 106:466–471.

    Article  CAS  Google Scholar 

  6. Gami AS, Pressman G, Caples SM, Kanagala R, Gard JJ, Davison DE, et al. Association of atrial fibrillation and obstructive sleep apnea. Circulation 2004; 110:364–367.

    Article  Google Scholar 

  7. Mehra R, Benjamin EJ, Shahar E, Gottlieb DJ, Nawabit R, Kirchner HL, et al. Association of nocturnal arrhythmias with sleep-disordered breathing. Am J Respir Crit Care Med 2006; 173:910–916.

    Article  Google Scholar 

  8. Roche F, Gaspoz JM, Court-Fortune I, Minini P, Pichot V, Duverney D, et al. Screening of obstructive sleep apnea syndrome by heart rate variability. Circulation 1999; 100:1411–1415.

    Article  CAS  Google Scholar 

  9. Galal I. Nocturnal heart rate variability analysis as a screening tool for obstructive sleep apnea syndrome. Egypt J Chest Dis Tuberc 2012; 61:187–195.

    Article  Google Scholar 

  10. Park DH, Shin CJ, Hong SC, Yu J, Ryu S, Kim E, et al. Correlation between the severity of obstructive sleep apnea and heart rate variability indices. J Korean Med Sci 2008; 23:226–231.

    Article  Google Scholar 

  11. Aydin M, Altin R, Ozeren A, Kart L, Bilge M, Unalacak M. Cardiac autonomic activity in obstructive sleep apnea: time-dependent and spectral analysis of heart rate variability using 24-hour Holter electrocardiograms. Tex Heart Inst J 2004; 31:132–136.

    PubMed  PubMed Central  Google Scholar 

  12. Wit AL, Rosen AR. After depolarizations and triggered activity. In: Fossard HA, Haber E, Jenning RB, Katz M, Morgan E, editors. The heart and cardiovascular system. New York, NY: Raven Press; 1986. pp.1449–1490.

  13. Zipers DP, Inoue H. Autonomic neural control of cardiac excitable properties. In: Kulbertus HE, Franck G, editors. Neurocardiology. New York, NY: Futura; 1988. pp. 59–84.

  14. Luenberger U, Jacob E, Sweer L, Waravdekar N, Zwillich C, Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 1995; 79:581–588.

    Article  Google Scholar 

  15. Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 1995; 96: 1897–1904.

    Article  CAS  Google Scholar 

  16. Xie A, Skatrud JB, Puleo DS, Morgan BJ. Exposure to hypoxia produces long-lasting sympathetic activation in humans. J Appl Physiol 2001; 91:1555–1562.

    Article  CAS  Google Scholar 

  17. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 1999; 99: 1183–1189.

    Article  CAS  Google Scholar 

  18. Dimsdale JE, Loredo JS, Profant J. Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000; 35:144–147.

    Article  CAS  Google Scholar 

  19. Narkiewicz K, van de Borne PJ, Cooley RL, Dyken ME, Somers VK. Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 1998; 98:772–776.

    Article  CAS  Google Scholar 

  20. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.Circulation 1996; 93:1043–1065.

  21. Jo JA, Blasi A, Valladares E, Juarez R, Baydur A, Khoo MC. Determinants of heart rate variability in obstructive sleep apnea syndrome during wakefulness and sleep. Am J Physiol Heart Circ Physiol 2005; 288:1103–1112.

    Article  Google Scholar 

  22. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342:1378–1384.

    Article  CAS  Google Scholar 

  23. Fletcher EC. Sympathetic over activity in the etiology of hypertension of obstructive sleep apnea. Sleep 2003; 26:15–19.

    Article  Google Scholar 

  24. Liston R, Deegan P, McCreery C, McNicholas WT. Role of respiratory sleep disorders in the pathogenesis of nocturnal angina and arrhythmias. Postgrad Med J 1994; 70:275–280.

    Article  CAS  Google Scholar 

  25. Maser RE, Lenhard MJ, Rizzo AA, Vasile AA. Continuous positive airway pressure therapy improves cardiovascular autonomic function for persons with sleep-disordered breathing. Chest 2008; 133:86–91.

    Article  Google Scholar 

  26. Berry RB, Brooks R, Gamaldo CE, Harding SM, Loyd RM, Vaughn BV. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications, version 2.3. Darien, IL: American Academy of Sleep Medicine; 2016.

  27. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: the Report of an AmericanAcademy ofSleepMedicineTaskForce. Sleep1999;22:667–689.

  28. Littner M, Hirshkowitz M, Davila D, Anderson WM, Kushida CA, Woodson BT, et al. Standards of Practice Committee of the American Academy of Sleep Medicine. Practice parameters for the use of auto-titrating continuous positive airway pressure devices for titrating pressures and treating adult patients with obstructive sleep apnea syndrome. An American Academy of Sleep Medicine report. Sleep 2002; 25:143–147.

    Article  Google Scholar 

  29. Kushida CA, Chediak A, Berry RB, Brown LK, Gozal D, Iber C, et al. Clinical Guidelines for the Manual Titration of Positive Airway Pressure in Patients with Obstructive Sleep Apnea. Positive Airway Pressure Titration Task Force of the American Academy of Sleep Medicine. J Clin SleepMed 2008; 4:157–171.

    Google Scholar 

  30. Marrone O, Insalaco G, Salvaggio A, Bonsignore G. Role of different nocturnal monitorings in the evaluation of CPAP titration by autoCPAP devices. Respir Med 2005; 99:313–320.

    Article  Google Scholar 

  31. Marrone O, Insalaco G, Bonsignore MR, Romano S, Salvaggio A, Bonsignore G. Sleep structure correlates of continuous positive airway pressure variations during application of an autotitrating continuous positive airway pressure machine in patients with obstructive sleep apnea syndrome. Chest 2002; 121:759–767.

    Article  Google Scholar 

  32. TeschlerH,Berthon-JonesM. IntelligentCPAPsystems, clinical experience. Thorax 1998; 53:S49–S54.

    Article  Google Scholar 

  33. Cross MD, Vennelle M, Engleman HM, White S, Mackay TW, Twaddle S, et al. Comparison of CPAP titration at home or the sleep laboratory in the sleep apnea hypopnea syndrome. Sleep 2006; 29:1451–1455.

    Article  Google Scholar 

  34. Narkiewicz K, Montano N, Cogliati C, van de Borne PJ, Dyken ME, Somers VK. Altered cardiovascular variability in obstructive sleep apnea. Circulation 1998; 98:1071–1077.

    Article  CAS  Google Scholar 

  35. Karasulu L, Epöztürk PO, Sökücü SN, Dalar L, Altin S. Improving Heart rate variability in sleep apnea patients: differences in treatment with autotitrating positive airway pressure (APAP) versus conventional CPAP. Lung 2010; 188:315–320.

    Article  Google Scholar 

  36. Chrysostomakis SI, Simantirakis EN, Schiza SE, Karalis IK, Klapsinos NC, Siafakas NM, et al. Continuous positive airway pressure therapy lowers vagal tone in patients with obstructive sleep apnoea-hypopnoea syndrome. Hellenic J Cardiol 2006; 47:13–20.

    PubMed  Google Scholar 

  37. Jennum P, Wildschiodtz G, Christensen NJ, Schwartz T. Blood pressure, catecholamines, and pancreatic polypeptide in obstructive sleep apnea with and without nasal continuous positive airway pressure (nCPAP) treatment. Am J Hypertens 1989; 2:847–852.

    Article  CAS  Google Scholar 

  38. Minemura H, Akashiba T, Yamamoto H, Akahoshi T, Kosaka N, Horie T. Acute effects of nasal continuous positive airway pressure on 24-hour blood pressure and catecholamines in patients with obstructive sleep apnea. Intern Med 1998; 37:1009–1013.

    Article  CAS  Google Scholar 

  39. Hedner J, Darpo B, Ejnell H, Carlson J, Caidahl K. Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. Eur Respir J 1995; 8:222–229.

    Article  CAS  Google Scholar 

  40. Cheng JH, Hua CC, Chen NH, Liu YC, Yu CC. Autonomic activity difference during continuous positive airway pressure titration in patients with obstructive sleep apnea/hypopnea syndrome with or without hypertension. Chang Gung Med J 2011; 34:410–417.

    PubMed  Google Scholar 

  41. Vanderlei LC, Pastre CM, Hoshi RA, Carvalho TD, Godoy MF. Basic notions of heart rate variability and its clinical applicability. Rev Bras Cir Cardiovasc 2009; 24:205–217.

    Article  Google Scholar 

  42. Heitmann J, Ehlenz K, Penzel T, Becker HF, Grote L, Voigt KH, et al. Sympathetic activity is reduced by nCPAP in hypertensive obstructive sleep apnoea patients. Eur Respir J 2004; 23:255–262.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Iman H. Galal MD, PhD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galal, I.H. Nocturnal heart rate variability in obstructive sleep apnea syndrome: effect of automatic positive airway pressure. Egypt J Bronchol 11, 372–378 (2017). https://doi.org/10.4103/ejb.ejb_36_17

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/ejb.ejb_36_17

Keywords